Archive — US — techcrunch
Verily is closing its medical device program as Alphabet shifts more resourcesto AI
Verily, Alphabet's life sciences unit, has eliminated its medical device program and laid off staff to refocus on AI and data infrastructure. CEO Stephen Gillett cited the need for difficult decisions as Alphabet continues to prioritize AI investment amid ongoing layoffs across its divisions.
Key points
- Verily laid off staff and shut down its medical device program.
- CEO Stephen Gillett mentioned the challenging decision in a staff memo.
- The shift to AI and data infrastructure reflects Alphabet's renewed focus in response to market trends.
- Alphabet has faced multiple layoffs recently, including significant cuts of 12,000 jobs in January 2023, targeting 6% of its workforce.
- The generative AI boom, ignited by the rapid growth of ChatGPT, is influencing the tech industry's investment priorities.
Why it matters
- The shift from medical devices to AI is a reflection of broader trends in healthcare technology, emphasizing digital health analytics.
- Similar organizational shifts are happening across tech companies as they adapt to economic pressures and changing consumer demands.
- The rise of generative AI is reshaping business models and prioritizing investments in data infrastructure and AI capabilities.
Verily's program closure exemplifies how Alphabet is navigating economic challenges and aligning with the booming AI landscape, indicating a significant pivot in tech priorities.